- Home
- WGSWW vs NYMTZ Comparison
WGSWW vs NYMTZ Comparison
Compare WGSWW & NYMTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WGSWW
- NYMTZ
- Stock Information
- Founded
- WGSWW 2017
- NYMTZ N/A
- Country
- WGSWW United States
- NYMTZ United States
- Employees
- WGSWW N/A
- NYMTZ N/A
- Industry
- WGSWW Retail: Computer Software & Peripheral Equipment
- NYMTZ Real Estate Investment Trusts
- Sector
- WGSWW Technology
- NYMTZ Real Estate
- Exchange
- WGSWW Nasdaq
- NYMTZ Nasdaq
- Market Cap
- WGSWW N/A
- NYMTZ N/A
- IPO Year
- WGSWW N/A
- NYMTZ N/A
- Fundamental
- Price
- WGSWW $0.17
- NYMTZ $19.00
- Analyst Decision
- WGSWW
- NYMTZ
- Analyst Count
- WGSWW 0
- NYMTZ 0
- Target Price
- WGSWW N/A
- NYMTZ N/A
- AVG Volume (30 Days)
- WGSWW 36.6K
- NYMTZ N/A
- Earning Date
- WGSWW 02-18-2025
- NYMTZ N/A
- Dividend Yield
- WGSWW N/A
- NYMTZ N/A
- EPS Growth
- WGSWW N/A
- NYMTZ N/A
- EPS
- WGSWW N/A
- NYMTZ N/A
- Revenue
- WGSWW $305,450,000.00
- NYMTZ N/A
- Revenue This Year
- WGSWW N/A
- NYMTZ N/A
- Revenue Next Year
- WGSWW N/A
- NYMTZ N/A
- P/E Ratio
- WGSWW N/A
- NYMTZ N/A
- Revenue Growth
- WGSWW 50.79
- NYMTZ N/A
- 52 Week Low
- WGSWW $0.17
- NYMTZ N/A
- 52 Week High
- WGSWW $0.21
- NYMTZ N/A
- Technical
- Relative Strength Index (RSI)
- WGSWW N/A
- NYMTZ 47.44
- Support Level
- WGSWW N/A
- NYMTZ $18.76
- Resistance Level
- WGSWW N/A
- NYMTZ $19.25
- Average True Range (ATR)
- WGSWW 0.00
- NYMTZ 0.22
- MACD
- WGSWW 0.00
- NYMTZ 0.02
- Stochastic Oscillator
- WGSWW 0.00
- NYMTZ 57.63
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.